Board of Directors

Dr. Huang is the CEO of MERIT and co-founded the company in 2012 with Dr. Christopher Murphy and Dr. Ronald Danis. Dr. Huang has 25+ years of experience in medical imaging, instrumentation, and clinical trial innovation. In addition to overseeing operations, he leads the development of MERIT’s software platform, EXCELSIOR^TM, which serves as the foundation for the company’s service offerings in clinical endpoint assessment.

Prior to co-founding MERIT, Dr. Huang was VP of Engineering at Topcon Medical Systems and a Senior Scientist at the University of Wisconsin-Madison. He received his Ph.D. in Bioengineering from the University of Pennsylvania.

Steve Yang launched Mianus Capital with MERIT CRO in 2023, leveraging MERIT’s expertise and resources to drive venture capital investment in early-stage biotech innovation. He brings over 20 years of experience spanning technology, consulting, finance, and healthcare. Mr. Yang has held senior management positions at prominent banking and investment firms, including Black River Asset Management, the Royal Bank of Scotland, and Nomura. He began his management career at McKinsey & Company in 2001.

Mr. Yang earned his MBA with high distinction from the University of Michigan, Ann Arbor. He also holds a master’s degree in Computer Science and a B.A. in Electrical and Computer Engineering, both from the University of Minnesota.